Leadership - DYSIS Medical

Leadership

DYSIS Medical is a forward-looking medical technology company that combines innovative computer-aided cervical mapping technology with advanced colposcope design to help healthcare professionals increase detection of cervical lesions and direct the patient journey with greater assurance.

    Yelena Tropsha

    Posted: July 23, 2021

    VP of Clinical, Regulatory and Quality Yelena joined DYSIS Medical in July 2021. She brings with her over 25 years of experience in global development of a wide range of medical devices. Most recently she served as the VP of…

    Read More

    Ken Reali

    Posted: July 12, 2021

    Ken is currently the CEO of Bioventus after being appointed to the role in April of 2020. Prior to that, Ken served as President and CEO of Clinical Innovations, a medical device company focused in woman’s healthcare, from June 2015…

    Read More

    Mette Kirstine Agger

    Posted: July 12, 2021

    Mette is the Managing Partner at The Lundbeck Foundation. Mette has extensive international experience in biotech / life sciences, more specifically business development and licensing, administration and financing. Mette has been appointed to several board positions at both private and…

    Read More

    Brent Palmisano

    Posted: May 5, 2021

    Senior VP Commercial Operations - Global Brent joined DYSIS Medical in March of 2019 as Senior Vice President of Sales and Marketing managing the global commercial organization. Brent previously spent 15 years at Boston Scientific where he held multiple commercial…

    Read More

    John Pedersen

    Posted: May 5, 2021

    John Pedersen joined DYSIS Medical as Chairman of the Board in December 2019.  Prior to joining the Board of Directors, John was CEO at Augmenix, Inc., which in was acquired by Boston Scientific Corp. in late 2018.  Previous to Augmenix,…

    Read More

    David Inman

    Posted: February 4, 2021

    Chief Financial Officer Dave joined the DYSIS Medical team in March 2020.  Prior to DYSIS, Dave was the VP of Finance and Accounting at Augmenix, Inc., which was sold to Boston Scientific at the end of 2018; Dave stayed at…

    Read More

    Casper Breum

    Posted: February 4, 2021

    Casper Breum was previously CEO of ilochip A/S, a venture backed company focused on development of diagnostic biochips. Before this he held different positions at H.Lundbeck A/S most recently in corporate business development and strategy where he gained broad international…

    Read More

    Alastair Atkinson

    Posted: January 28, 2021

    Chief Operating Officer Alastair has over 25 years of Product Marketing, Development, Manufacturing and Sales experience within both corporate and start-up environments. He joined DYSIS Medical from Optos plc where he served as the European General Manager, Global Product Director…

    Read More

    Darin Hammers

    Posted: January 28, 2021

    Chief Executive Officer Darin Hammers has served as Chief Executive Officer of the Company since September 2018. Mr. Hammers’ experience includes over 25 years of increasing leadership roles in Gynecology and Urology. Prior to joining DYSIS, he served as the…

    Read More